tradingkey.logo
tradingkey.logo
Search

STRATA Skin Sciences Inc

SSKN
Add to Watchlist
0.190USD
0.0000.00%
Close 07/02, 13:00ETQuotes delayed by 15 min
765.47KMarket Cap
LossP/E TTM

TradingKey Stock Score of STRATA Skin Sciences Inc

Currency: USD Updated: 2026-02-18

Key Insights

STRATA Skin Sciences Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 101 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 10.80.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

STRATA Skin Sciences Inc's Score

Industry at a Glance

Industry Ranking
101 / 206
Overall Ranking
272 / 4504
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

STRATA Skin Sciences Inc Highlights

StrengthsRisks
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Growing
The company is in a growing phase, with the latest annual income totaling USD 33.56M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 33.56M.
Overvalued
The company’s latest PE is -0.07, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.56M shares, decreasing 4.02% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 63.83K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 16.43.

Analyst Rating

Based on 0 analysts
--
Current Rating
10.800
Target Price
+3314.48%
Upside Space

FAQs

How does TradingKey generate the Stock Score of STRATA Skin Sciences Inc?

The TradingKey Stock Score provides a comprehensive assessment of STRATA Skin Sciences Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of STRATA Skin Sciences Inc’s performance and outlook.

How do we generate the financial health score of STRATA Skin Sciences Inc?

To generate the financial health score of STRATA Skin Sciences Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects STRATA Skin Sciences Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of STRATA Skin Sciences Inc.

How do we generate the company valuation score of STRATA Skin Sciences Inc?

To generate the company valuation score of STRATA Skin Sciences Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare STRATA Skin Sciences Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of STRATA Skin Sciences Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of STRATA Skin Sciences Inc.

How do we generate the earnings forecast score of STRATA Skin Sciences Inc?

To calculate the earnings forecast score of STRATA Skin Sciences Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on STRATA Skin Sciences Inc’s future.

How do we generate the price momentum score of STRATA Skin Sciences Inc?

When generating the price momentum score for STRATA Skin Sciences Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of STRATA Skin Sciences Inc’s prices. A higher score indicates a more stable short-term price trend for STRATA Skin Sciences Inc.

How do we generate the institutional confidence score of STRATA Skin Sciences Inc?

To generate the institutional confidence score of STRATA Skin Sciences Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about STRATA Skin Sciences Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of STRATA Skin Sciences Inc.

How do we generate the risk management score of STRATA Skin Sciences Inc?

To assess the risk management score of STRATA Skin Sciences Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of STRATA Skin Sciences Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of STRATA Skin Sciences Inc.